Scarica l'app Stockscreener
62.58
4.39%
2.63
Dopo l'orario di chiusura:
62.58
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KROS Giù?
Forum
Previsione
Keros Therapeutics Inc Borsa (KROS) Ultime notizie
Keros Therapeutics (NASDAQ:KROS) Now Covered by Jefferies Financial Group - MarketBeat
(KROS) Proactive Strategies - Stock Traders Daily
Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition - GlobeNewswire
Mirae Asset Global Investments Co. Ltd. Boosts Stock Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
Emerald Advisers LLC Acquires Shares of 155,545 Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Brokerages Set Keros Therapeutics, Inc. (NASDAQ:KROS) PT at $89.11 - Defense World
Keros Therapeutics, Inc. (NASDAQ:KROS) Short Interest Update - MarketBeat
Analysts Offer Predictions for KROS FY2024 Earnings - Defense World
Assenagon Asset Management S.A. Boosts Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Cantor Fitzgerald Weighs in on KROS FY2024 Earnings - Defense World
Brokers Set Expectations for KROS FY2024 Earnings - MarketBeat
Keros Therapeutics (NASDAQ:KROS) Now Covered by Cantor Fitzgerald - Defense World
(KROS) Trading Signals - Stock Traders Daily
Cantor Fitzgerald initiates coverage on Keros Therapeutics shares with Overweight rating - Investing.com India
Cantor Fitzgerald initiates coverage on Keros Therapeutics shares with Overweight rating By Investing.com - Investing.com South Africa
Cantor Fitzgerald Initiates Coverage on Keros Therapeutics (NASDAQ:KROS) - MarketBeat
Keros Therapeutics (NASDAQ:KROS) Now Covered by Scotiabank - MarketBeat
Keros Therapeutics appoints new Chief Medical Officer - Investing.com
Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer - GlobeNewswire
Keros Therapeutics appoints new Chief Medical Officer By Investing.com - Investing.com UK
Keros Therapeutics, Inc. Appoints Yung H. Chyung as Chief Medical Officer, Effective as of November 1, 2024 - Marketscreener.com
Short Interest in Keros Therapeutics, Inc. (NASDAQ:KROS) Declines By 13.7% - MarketBeat
Objective long/short (KROS) Report - Stock Traders Daily
Renaissance Technologies LLC Invests $654,000 in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
Renaissance Technologies LLC Acquires New Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Marshall Wace LLP Has $1.02 Million Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
Dimensional Fund Advisors LP Sells 3,691 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
19,832 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Bought by Squarepoint Ops LLC - Defense World
Squarepoint Ops LLC Buys New Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Point72 Asia Singapore Pte. Ltd. Buys New Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
Keros Therapeutics, Inc. (NASDAQ:KROS) Receives $90.63 Consensus PT from Analysts - MarketBeat
Understanding the Risks of Investing in Keros Therapeutics Inc (KROS) - Knox Daily
Keros Therapeutics completes enrollment for TROPOS trial - Investing.com India
Leerink Partners sees favorable conditions for Keros Therapeutics shares amid competitive landscape with Winrevair - Investing.com Canada
Nantahala Capital Management LLC Grows Stock Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
Nantahala Capital Management LLC Acquires 84,810 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Point72 Asset Management L.P. Cuts Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
Keros Therapeutics completes enrollment for TROPOS trial By Investing.com - Investing.com South Africa
Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Sold by Point72 Asset Management L.P. - MarketBeat
Wells Fargo Initiates Coverage of Keros Therapeutics (KROS) with Overweight Recommendation - MSN
Point72 Asia Singapore Pte. Ltd. Purchases New Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
Blue Owl Capital Holdings LP Sells 15,000 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Fred Alger Management LLC Has $2.24 Million Stock Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
Iron Deficiency Anemia Market Expected to Experience Major Growth by 2034, According to DelveInsight | Shield Therapeutics, Zeria Pharma, Keros Therapeutics - The Globe and Mail
Darwin Global Management Ltd. Boosts Stake in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
Myelofibrosis Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies by DelveInsight | Galecto Biotech, Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo - The Globe and Mail
17,540 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Purchased by Point72 DIFC Ltd - MarketBeat
Keros Therapeutics Inc [KROS] Insider GORDON CARL L sells 250,000 Shares for $250,000 - Knox Daily
Keros Therapeutics Inc (KROS)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Keros Therapeutics (NASDAQ:KROS) Shares Gap Up to $55.80 - Defense World
Keros Therapeutics (NASDAQ:KROS) Receives New Coverage from Analysts at Guggenheim - Defense World
Integral Health Asset Management LLC Acquires 45,000 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
How the (KROS) price action is used to our Advantage - Stock Traders Daily
How does Keros Therapeutics Inc (KROS) change from a tortoise to a hare? - SETE News
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):